Getting comfortable: clonal haematopoiesis creates a senescent niche for expansion.

Senescent bone marrow stromal cells promote clonal haematopoiesis expansion by supporting mutant HSPCs, with senescence depletion reducing disease progression.

• Why it matters: Understanding how mutant haematopoietic clones outcompete normal cells is crucial for developing early interventions in age-related blood disorders and preventing progression to myeloid neoplasia.
• What they did: Mistry et al. used mouse models and human samples to show that mutant haematopoietic cells induce MSC senescence via cytokine signaling involving TNF-α, IL-6, and STAT3, which favors mutant HSPC growth.
• The result: Targeting senescent MSCs decreased clonal haematopoiesis burden and delayed disease progression, highlighting MSC senescence as a promising therapeutic target to prevent malignant transformation.